Rebiotix Inc.: Clinical Trials

3 trials sponsored by Rebiotix Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow Rebiotix Inc.: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fecal Microbiota Transplantation (FMT) for MDRO UTI
Fecal microbiota transplant - Urinary Tract Infections
Phase 1 / Phase 2CompletedWashington University School of Medicine12018-02-082022-03-18
Treatment of Recurrent Clostridium Difficile Infection With RBX7455
RBX7455 - Clostridium Difficile Infection
Phase 1CompletedMayo Clinic302016-11-012020-12-08
Fecal Transplant for Hepatic Encephalopathy
FMT - Hepatic Encephalopathy
Phase 1 / Phase 2CompletedUniversity of Alberta32016-04-122022-06-10

Conditions studied

Clostridium Infections (1)  ·  Hepatic Encephalopathy (1)  ·  Urinary Tract Infections (1)

Interventions

Fecal Microbiota Transplantation (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Dina Kao, MD (1)  ·  Erik Dubberke, MD, MSPH (1)  ·  Sahil Khanna (1)

Results publications

PMID 32966574, PMID 38109364